Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Oncologist 29 (2), 132141
It increases insulin production, lipolysis (GLP-1), cardio-protection (GLP-1) and lipogenesis (GIP) in the pancreas
doi: 10.1080/19490976.2022.2038856 Summary Keywords gut microbiota, metabolite, cardiovascular disease, trimethylamine N-oxide, targeted therapy Citation Zhen J, Zhou Z, He M, Han H-X, Lv E-H, Wen P-B, Liu X, Wang Y-T, Cai X-C, Tian J-Q, Zhang M-Y, Xiao L and Kang X-X (2023) The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
Microbiol 9 , 14671482 (2024)
US$ 26.58
US$ 27.88
US$ 21.05
